Evolent Health Inc Class A Forecast, price target & analysts
Evolent Health Inc Class A Target price 2025 - Analyst rating & recommendation
Evolent Health Inc Class A Classifications & Recommendation:
Evolent Health Inc Class A Price Target
| Target Price | $15.23 |
| Price | $10.08 |
| Potential |
51.10%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Evolent Health Inc Class A 2026 .
The average Evolent Health Inc Class A target price is $15.23.
This is
51.10%
register free of charge
$20.00
98.41%
register free of charge
$12.00
19.05%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Evolent Health Inc Class A to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Evolent Health Inc Class A stock has an average upside potential 2026 of
51.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.55 | 2.07 |
| 30.09% | 19.02% | |
| EBITDA Margin | 4.91% | 7.23% |
| 37.43% | 47.18% | |
| Net Margin | -3.65% | -3.53% |
| 51.35% | 3.22% |
13 Analysts have issued a sales forecast Evolent Health Inc Class A 2025 . The average Evolent Health Inc Class A sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Evolent Health Inc Class A EBITDA forecast 2025. The average Evolent Health Inc Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Evolent Health Inc Class A Analysts have issued a net profit forecast 2025. The average Evolent Health Inc Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.81 | -0.63 |
| 36.72% | 22.22% | |
| P/E | negative | |
| EV/Sales | 0.93 |
9 Analysts have issued a Evolent Health Inc Class A forecast for earnings per share. The average Evolent Health Inc Class A EPS is
This results in the following potential growth metrics and future valuations:
Evolent Health Inc Class A...
Current Evolent Health Inc Class A Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Feb 24 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jan 28 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Mar 10 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Feb 24 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Feb 14 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Feb 12 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jan 28 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
